Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and ...
First quarter 2026 total revenues were US$72.4 million, an 8% decrease compared to the first quarter 2025 RUCONEST® revenue was US$58.4 million, a 15% decrease compared to the first quarter 2025, mainly due to anticipated inventory drawdowns and the …